title: Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study.
abstract: OBJECTIVE
  To assess the efficacy of a lifestyle intervention program that can be readily translated into clinical practice for obese patients with type 2 diabetes.
  
  
  METHODS
  The study consisted of a 12-month randomized controlled trial of 147 health plan members with type 2 diabetes and obesity (BMI >or=27 kg/m(2)). Participants were randomized to lifestyle case management or usual care. Case management entailed individual and group education, support, and referral by registered dietitians; intervention cost was US dollars 350 per person. Individuals treated with usual care received educational material. Both groups received ongoing primary care. Outcomes were difference between groups for change in weight (kilograms), waist circumference (centimeters), HbA(1c), fasting lipid levels, use of prescription medications, and health-related quality of life.
  
  
  RESULTS
  Case management resulted in greater weight loss (P < 0.001), reduced waist circumference (P < 0.001), reduced HbA(1c) level (P = 0.02), less use of prescription medications (P = 0.03), and improved health-related quality of life (P < 0.001) compared with usual care. The 12-month group difference in weight loss and waist circumference was 3.0 kg (95% CI -5.4 to -0.6) and -4.2 cm (-6.8 to -1.6). HbA(1c) differences were greatest at 4 months (-0.59%, P = 0.006) but not significant by 12 months (-0.19%, P = 0.45). Participants in the case management group lowered their use of medications, primarily diabetes medications, by 0.8 medications per day more than participants treated with usual care (P = 0.03). In seven of nine quality-of-life domains, the case management group improved compared with usual care (P < 0.05).
  
  
  CONCLUSIONS
  Moderate-cost dietitian-led lifestyle case management may improve diverse health indicators among obese patients with type 2 diabetes.
authors.affiliation: Department of Health Evaluation Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908-0717, USA. amw6n@virginia.edu
authors.forename: Anne M
authors.initials: AM
authors.lastname: Wolf
authors.forename: Mark R
authors.initials: MR
authors.lastname: Conaway
authors.forename: Jayne Q
authors.initials: JQ
authors.lastname: Crowther
authors.forename: Kristen Y
authors.initials: KY
authors.lastname: Hazen
authors.forename: Jerry
authors.initials: J
authors.lastname: L Nadler
authors.forename: Beverly
authors.initials: B
authors.lastname: Oneida
authors.forename: Viktor E
authors.initials: VE
authors.lastname: Bovbjerg
mesh_terms: D015992:Body Mass Index; D001835:Body Weight; D003920:Diabetes Mellitus / Q000523:psychology / Q000534:rehabilitation*; D003924:Diabetes Mellitus, Type 2 / Q000523:psychology / Q000534:rehabilitation*; D005260:Female; D006304:Health Status; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D013997:Time Factors